findmyKOL
Clinical trialNCT05089435UnknownPhase 4Interventional

An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients

SponsorSigknow Biomedical Co., Ltd.Enrollment500Atrial FibrillationEmbolic Stroke of Undetermined Source
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • National Taiwan University Hospital

    Taipei, Taiwan

    Jiann-Shing Jeng, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Mar 2022
Primary completion
31 Mar 2023
Completion
31 Dec 2023
Last update posted
10 May 2022
Registered enrollment
500
Registry id
NCT05089435
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.